Source link : https://newshealth.biz/health-news/baricitinib-misses-key-safety-benchmark-in-high-risk-ra/
Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease or cancer, according to two safety trials. Medscape Medical News Source link : https://www.medscape.com/viewarticle/baricitinib-misses-key-safety-benchmark-blood-clots-and-2026a1000iyi?src=rss Author : Publish date : 2026-06-06 20:49:00 Copyright for syndicated content belongs to the linked Source.
The post Baricitinib Misses Key Safety Benchmark in High-Risk RA first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-06 20:49:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8